Dose finding studies for therapies with late-onset toxicities: a comparison study of designs
From MaRDI portal
Publication:6629421
DOI10.1002/SIM.9593zbMATH Open1547.62135MaRDI QIDQ6629421
Author name not available (Why is that?), Oliver Boix, Dimitris Kontos, Thomas Jaki
Publication date: 30 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Design and Analysis of Phase I Clinical Trials
- Determining the Effective Sample Size of a Parametric Prior
- Bayesian decision procedures based on logistic regression models for dose-finding studies
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
- Quantification of prior impact in terms of effective current sample size
- Predictively consistent prior effective sample sizes
- Non-parametric optimal design in dose finding studies
This page was built for publication: Dose finding studies for therapies with late-onset toxicities: a comparison study of designs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629421)